Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Calgary

$150,000.00

Genetic variance in the endocannabinoid system and vulnerability towards the impact of early life adversity on emotional behavior and sensitivity to stress: An examination of gene-environment interactions relevant for psychiatric illness.

FY 2017-18

Summary
Early life adversity (ELA; i.e. childhood trauma or abuse) is known to be a significant risk factor for development of anxiety disorder, which are among the most prevalent psychiatric conditions in children and adolescents. However, a significant proportion of individuals who experience ELA do not develop psychiatric issues later in life. This suggests that there is a gene-environment interaction that can regulate the effects of early life experience on the developing brain. The endocannabinoid system, a signaling system in the brain, is known to be involved in regulation of stress, fear, and anxiety. Interestingly, a relatively common genetic alteration in this system (present in ~38% of the population) has been shown to enhance top-down control of emotionality and promote resilience against anxiety. However, the influence of this gene alteration may depend on environmental conditions present during development. A recent report identified that individuals with this gene alteration may actually exhibit an increased vulnerability, not resilience, to develop anxiety disorders, if they were exposed to ELA. The following proposal utilizes this gene-environment interaction in order to examine the molecular, biochemical, and genetic link between ELA and anxiety disorders. Specifically, this proposal uses two well-established mouse models to investigate the effects of ELA in mice with the endocannabinoid gene alteration on: 1) activity and connectivity of specific neural circuitry (frontoamygdala circuitry, which is implicated in anxiety); 2) stress response; and 3) anxiety and stress-coping behaviour. Importantly, with the high prevalence of anxiety disorders, overrepresentation of ELA in anxiety patients, and commonality of endocannabinoid gene alteration it is likely that many individuals diagnosed with anxiety disorders have unique neural circuitry underlying their symptoms. Thus, these experiments may provide an avenue into more personalized treatment of anxiety.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
377311
Name
Baglot Samantha L
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Genetic variance in the endocannabinoid system and vulnerability towards the impact of early life adversity on emotional behavior and sensitivity to stress: An examination of gene-environment interactions relevant for psychiatric illness.
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Amygdala; Anxiety; Early Life Adversity; Endocannabinoid System; Fatty Acid Amide Hydrolase; Genetic Polymorphism; Hypothalamic-Pituitary-Adrenal Axis; Prefrontal Cortex; Sex Differences; Stress Coping
Abstract
Early life adversity (ELA; i.e. childhood trauma or abuse) is known to be a significant risk factor for development of anxiety disorder, which are among the most prevalent psychiatric conditions in children and adolescents. However, a significant proportion of individuals who experience ELA do not develop psychiatric issues later in life. This suggests that there is a gene-environment interaction that can regulate the effects of early life experience on the developing brain. The endocannabinoid system, a signaling system in the brain, is known to be involved in regulation of stress, fear, and anxiety. Interestingly, a relatively common genetic alteration in this system (present in ~38% of the population) has been shown to enhance top-down control of emotionality and promote resilience against anxiety. However, the influence of this gene alteration may depend on environmental conditions present during development. A recent report identified that individuals with this gene alteration may actually exhibit an increased vulnerability, not resilience, to develop anxiety disorders, if they were exposed to ELA. The following proposal utilizes this gene-environment interaction in order to examine the molecular, biochemical, and genetic link between ELA and anxiety disorders. Specifically, this proposal uses two well-established mouse models to investigate the effects of ELA in mice with the endocannabinoid gene alteration on: 1) activity and connectivity of specific neural circuitry (frontoamygdala circuitry, which is implicated in anxiety); 2) stress response; and 3) anxiety and stress-coping behaviour. Importantly, with the high prevalence of anxiety disorders, overrepresentation of ELA in anxiety patients, and commonality of endocannabinoid gene alteration it is likely that many individuals diagnosed with anxiety disorders have unique neural circuitry underlying their symptoms. Thus, these experiments may provide an avenue into more personalized treatment of anxiety.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Baglot, Samantha L
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~